Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Lol

<< Previous

Bullboard Posts

Next >>

Comment by Rawrasauruson Aug 19, 2021 4:23pm

146 Views

Post# 33734660

RE:RE:RE:RE:RE:RE:RE:RE:RE:Lol

Prove that the car is owned and not leased, paid off in full, and that you are self made without a trust fund or assitance from your parents. If you can do that, I'll be impressed by your trading prowess. Otherwise all I see, is a sad, lonely, child whose parents failed miserably by making you think a 240k car means that you matter as an individual when it is really just a status symbol that signifies that you are a fool that easily parts with their money.

Best of luck to you in all future endeavours. Please seek therapy.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market